Consistent with this hypothesis, patients with acute type A AD have higher plasma ACAN than patients with TAA or healthy volunteers (König et al, 2021), supporting the possible use of ACAN as a prognostic biomarker for AD. Here, ACAN is linked to Alzheimer disease.